Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12, issue 10 (2010):848 –855] (Neoplasia (2010) 12(10) (848–855), (S1476558610800521), (10.1593/neo.10704));Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eif4F assembly through direct dephosphorylation of mnk and eif4E

Neoplasia

Volumn 12, Issue 10, 2010, Pages 848-855

  Li, Yikun ^a   Yue, Ping ^a   Deng, Xingming ^a   Ueda, Takeshi ^b   Fukunaga, Rikiro ^c   Khuri, Fadlo R ^a   Sun, Shi Yong ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4F; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYC PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN MCL 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 77957765231     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2024.101031     Document Type: Erratum

References (34)

1. Goodfellow IG and Roberts LO (2008). Eukaryotic initiation factor 4E. Int J Biochem Cell Biol 40, 2675-2680.
2. Thumma SC and Kratzke RA (2007). Translational control: a target for cancer therapy. Cancer Lett 258, 1-8.
3. Graff JR, Konicek BW, Carter JH, and Marcusson EG (2008). Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 68, 631-634.
4. Clemens MJ (2004). Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23, 3180-3188.
5. De Benedetti A and Graff JR (2004). EIF-4E expression and its role in malignancies and metastases. Oncogene 23, 3189-3199.
6. Raught B and Gingras AC (1999). EIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol 31, 43-57.
7. Pyronnet S (2000). Phosphorylation of the cap-binding protein eIF4E by the MAPK-activated protein kinase Mnk1. Biochem Pharmacol 60, 1237-1243.
8. Mahalingam M and Cooper JA (2001). Phosphorylation of mammalian eIF4E by Mnk1 and Mnk2: tantalizing prospects for a role in translation. Prog Mol Subcell Biol 27, 132-142.
9. Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Teruya-Feldstein J, Pelletier J, et al. (2007). Dissecting eIF4E action in tumorigenesis. Genes Dev 21, 3232-3237.
10. Westermarck J and Hahn WC (2008). Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 14, 152-160.
11. Van Hoof C and Goris J (2004). PP2A fulfills its promises as tumor suppressor: which subunits are important? Cancer Cell 5, 105-106.
12. Mumby M (2007). PP2A: unveiling a reluctant tumor suppressor. Cell 130, 21-24.
13. Eichhorn PJ, Creyghton MP, and Bernards R (2009). Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 1795, 1-15.
14. Rychlik W, Rush JS, Rhoads RE, and Waechter CJ (1990). Increased rate of phosphorylation-dephosphorylation of the translational initiation factor eIF-4E correlates with the induction of protein and glycoprotein biosynthesis in activated B lymphocytes. J Biol Chem 265, 19467-19471.
15. Bu X, Haas DW, and Hagedorn CH (1993). Novel phosphorylation sites of eukaryotic initiation factor-4F and evidence that phosphorylation stabilizes interactions of the p25 and p220 subunits. J Biol Chem 268, 4975-4978.
16. Bu X and Hagedorn CH (1992). Phosphoprotein phosphatase 2A dephosphorylates eIF-4E and does not alter binding to the mRNA cap. FEBS Lett 301, 15-18.
17. O'Loghlen A, Gonzalez VM, Pineiro D, Perez-Morgado MI, Salinas M, andMartin ME (2004). Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1. Exp Cell Res 299, 343-355.
18. Ogris E, Gibson DM, and Pallas DC (1997). Protein phosphatase 2A subunit assembly: the catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen. Oncogene 15, 911-917.
19. Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, and Fukunaga R (2004). Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24, 6539-6549.
20. Wang X, Yue P, Chan CB, Ye K, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Fu H, Khuri FR, and Sun SY (2007). Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3 kinase-dependent and Mnk-mediated eIF4E phosphorylation. Mol Cell Biol 27, 7405-7413.
21. Liu X, Yue P, Zhou Z, Khuri FR, and Sun SY (2004). Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 96, 1769-1780.
22. Wang X and Proud CG (2007). Methods for studying signal-dependent regulation of translation factor activity. Methods Enzymol 431, 113-142.
23. Liu L, Chen L, Luo Y, Chen W, Zhou H, Xu B, Han X, Shen T, and Huang S (2010). Rapamycin inhibits IGF-1 stimulated cell motility through PP2A pathway. PLoS One 5, e10578.
24. Xing H, Vanderford NL, and Sarge KD (2008). The TBP-PP2A mitotic complex bookmarks genes by preventing condensin action. Nat Cell Biol 10, 1318-1323.
25. Alvarado-Kristensson M and Andersson T (2005). Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J Biol Chem 280, 6238-6244.
26. Liu Q and Hofmann PA (2004). Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am J Physiol Heart Circ Physiol 286, H2204-H2212.
27. Scheper GC and Proud CG (2002). Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur J Biochem 269, 5350-5359.
28. Richter JD and Sonenberg N (2005). Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433, 477-480.
29. Bjornsti MA and Houghton PJ (2004). Lost in translation: dysregulation of capdependent translation and cancer. Cancer Cell 5, 519-523.
30. Arnold HK and Sears RC (2006). Protein phosphatase 2A regulatory subunit B56α associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol 26, 2832-2844.
31. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, et al. (2004). A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6, 308-318.
32. Joshi-Barve S, Rychlik W, and Rhoads RE (1990). Alteration of the major phosphorylation site of eukaryotic protein synthesis initiation factor 4E prevents its association with the 48 S initiation complex. J Biol Chem 265, 2979-2983.
33. Morley SJ, Dever TE, Etchison D, and Traugh JA (1991). Phosphorylation of eIF-4F by protein kinase C or multipotential S6 kinase stimulates protein synthesis at initiation. J Biol Chem 266, 4669-4672.
34. Wang CY, Lin YS, Su WC, Chen CL, and Lin CF (2009). Glycogen synthase kinase-3 and Omi/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis. Mol Biol Cell 20, 4153-4161.